Impact of Continuous Isotonic Saline Nebulisation Combined With Heated Humidification on the Rheology of Bronchial Secretions.

Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorCliniques universitaires Saint-Luc- Université Catholique de Louvain

About this trial

This study aims to evaluate whether adding a continuous mist of saltwater (saline nebulization) to warmed, humidified air can improve the properties of mucus in the lungs compared to humidified air alone.

Some patients with chronic lung diseases produce large amounts of thick mucus, which can be difficult to clear and may worsen breathing. Making this mucus easier to move and remove could help improve comfort and breathing.

In this study, 35 adult patients hospitalized for lung conditions with excessive mucus production will participate. Each patient will receive both treatments on two different days, in a random order:

Heated humidified air alone Heated humidified air combined with continuous saline nebulization This design allows each patient to serve as their own comparison. At the beginning and end of each session, a physiotherapist will help patients clear their airways, and mucus samples will be collected. Each treatment session will last 4 hours.

The collected mucus will be analyzed in a laboratory to measure how thick, sticky, or elastic it is, and how much force is needed to move it. The main goal is to determine whether the combined treatment makes mucus easier to clear.

The study will also assess patient comfort, breathing difficulty, ease of clearing mucus, and sleep quality after treatment.

The results of this study may help improve airway care for patients with chronic lung diseases by identifying more effective ways to manage excessive mucus.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

Age > 18 years old

Hospitalized in pulmonology unit

Excessive airways secretions disease: COPD, Bronchiectassies, Cystic Fibrosis, Primary Ciliary Diskynesia

Disqualifiers

Age < 18 years old

Under invasive or non invasive ventilation

>15L/min of oxygen

Mucoactive treatment

Trial design

Design model

Crossover

Treatments tested in this trial

  • Saline Nebulization

    Device

    Continuous saline nebulization through HFNC

  • Heated humidification

    Device

    Heated humidification through HFNC

Treatment groups

35 Participants
are divided into 2 treatment groups
Group A: Saline + HumidificationExperimental treatment 2 interventions
Group B: HumidificationActive comparator 1 intervention

Trial outcomes

Primary outcomes

1

Critical strain

Rheological property

Time frame
On each experimental session (4hours) the outcome will be measured at the onset on the experiment, which mean prior to the application of the treatment / control and at the end of the experiment which mean 4 hours after the onset.

Secondary outcomes

1

Elastic and viscous modulus

Time frame
On each experimental session (4hours) the outcome will be measured at the onset on the experiment, which mean prior to the application of the treatment / control and at the end of the experiment which mean 4 hours after the onset.
2

Comfort

Lickert scale 0 - 6, higher score is a better outcome

Time frame
On each experimental session (4hours) the outcome will be measured at the onset on the experiment, which mean prior to the application of the treatment / control and at the end of the experiment which mean 4 hours after the onset.
3

Dyspnea

Borge modified scale 0 - 10, higher score is a worse outcome

Time frame
On each experimental session (4hours) the outcome will be measured at the onset on the experiment, which mean prior to the application of the treatment / control and at the end of the experiment which mean 4 hours after the onset.
4

Sleep Quality

Lickert scale 0 - 6, higher score is a better outcome

Time frame
1 day Follow up

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

Cliniques universitaires Saint-Luc- Université Catholique de Louvain

Lead sponsor

Fisher and Paykel Healthcare

Collaborator

Aerogen

Collaborator

This trial is not recruiting at the moment. You can still explore other options: